https://www.linkedin.com/jobs/view/3922102066
closing date of 3 June 2024.
Thanks
Alex Bullock
alex.bull...@cmd.ox.ac.uk<mailto:alex.bull...@cmd.ox.ac.uk>
To unsubscribe from the CCP4BB list, click the following
n_4.display_form?p_company=10_internal_external=E_display_in_irish=N_process_type=_applicant_no=_form_profile_detail=_display_apply_ind=Y_refresh_search=Y_recruitment_id=162042>
Prof Alex Bullock
Centre for Medicines Discovery
Nuffield Dept of Medicine
University of Oxford
https://www.cmd.ox.ac.uk/tea
ndaphd.com/phds/project/structural-biology-of-receptor-kinase-signalling-driving-cancer-and-genetic-disease/?p141576>
Informal enquires can be made to
alex.bull...@cmd.ox.ac.uk<mailto:alex.bull...@cmd.ox.ac.uk>
Thanks
Alex.
https://www.cmd.ox
A postdoc position is available in the group of Alex Bullock, University of
Oxford, to study the structural and chemical biology of E3 Ligases as part of
the EU-funded "EUbOpen" consortium, with funding until 30 April 2025. The
project will support the next generation of PROTACs/molec
Two postdoctoral positions are available in the group of Alex Bullock,
University of Oxford. The posts will support the EU-funded "EUbOpen" consortium
that aims to generate chemical inhibitors for druggable protein families,
including ubiquitin ligases (E3s) and solute carriers (S
We are seeking a highly motivated Senior Scientist with an interest in drug
discovery and rare diseases to join the new Centre for Medicines Discovery at
the University of Oxford. The successful candidate will initially join the
group of Alex Bullock for work on an EU-funded project, "EU
structural-and-chemical-biology-of-e3-ligases
Alex Bullock
Nuffield Department of Medicine
University of Oxford
https://www.eubopen.org/
https://www.cmd.ox.ac.uk/team/alex-bullock
https://www.cmd.ox.ac.uk/news/work-starts-on-international-eubopen-chemogenom
I hope this will PI job posting might interest some of you...
A Principal Investigator post is available at the University of Oxford to lead
an existing medium-sized research group participating in the EU IMI2 EUbOpen
and ReSOLUTE consortia. The group is focused on the structure determination
iff/Dundee/British Columbia and
will showcase novel potential targets for translational research, including
results from the SGC's Target Enabling Packages (TEPs) programme. A poster
session will also be held.
For any queries, please contact
jonathan.l...@sgc.ox.ac.uk<mailto:jonathan.l...@sgc.ox
to:jonathan.l...@sgc.ox.ac.uk>
Alex Bullock
SGC Oxford
ship is available for UK
nationals only, but funding options are available for other nationalities.
Application and project details are copied below:
Characterisation of the drug target ACVR1/ALK2
Supervisors: Dr Alex Bullock, Dr Gillian Farnie
Project Overview
A multidisciplinary DPhil pro
cancer. The second
position with Alex Bullock is to characterise the structure and inhibition of
kinases implicated in Huntington's disease. Applicants interested in either
position can apply using the posting on jobs.ac.uk linked below (closing date
12 noon on 26 August 2014):
http
12 matches
Mail list logo